PTCT FY 2024 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$6B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$807M-14.0% YoY

Gross Profit

$749M92.9% margin

Operating Income

-$303M-37.5% margin

Net Income

-$363M-45.0% margin

EPS (Diluted)

$-4.73

Cash Flow

Operating Cash Flow

-$108M

Free Cash Flow

-$182M

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$2.8B

Stockholders' Equity

-$1.1B

Cash & Equivalents

$780M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$807M	$938M	-14.0%
Gross Profit	$749M	$872M	-14.1%
Operating Income	-$303M	-$440M	+31.2%
Net Income	-$363M	-$627M	+42.0%